Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $379.4 million.

  • Maravai Lifesciences Holdings' Total Non-Current Liabilities fell 3794.37% to $379.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $379.4 million, marking a year-over-year decrease of 3794.37%. This contributed to the annual value of $378.6 million for FY2024, which is 4066.99% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Total Non-Current Liabilities of $379.4 million as of Q3 2025, which was down 3794.37% from $390.8 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Total Non-Current Liabilities peaked at $1.4 billion during Q3 2021, and registered a low of $378.6 million during Q4 2024.
  • In the last 5 years, Maravai Lifesciences Holdings' Total Non-Current Liabilities had a median value of $1.3 billion in 2021 and averaged $972.6 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Total Non-Current Liabilities surged by 1958.63% in 2021 and then tumbled by 5487.28% in 2024.
  • Maravai Lifesciences Holdings' Total Non-Current Liabilities (Quarter) stood at $1.3 billion in 2021, then dropped by 1.78% to $1.3 billion in 2022, then tumbled by 51.22% to $638.1 million in 2023, then tumbled by 40.67% to $378.6 million in 2024, then rose by 0.21% to $379.4 million in 2025.
  • Its Total Non-Current Liabilities was $379.4 million in Q3 2025, compared to $390.8 million in Q2 2025 and $385.5 million in Q1 2025.